THE ROLE OF COST-EFFECTIVENESS ANALYSIS IN DEFINING TRANSFUSION MEDICINE POLICY

机译：成本效益分析在定义输血医学政策中的作用

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Government officials, administrators and physicians charged with providing a safe blood supply face a difficult dilemma. After enduring decades of hepatitis C (HCV) risk without effective means to detect carriage of the causative agent and after discovering the havoc that can be wrought by a lethal, blood-borne immunodeficiency virus with a long incubation period, enhanced donor screening and testing tools have reduced infectious disease risks in the allogeneic blood supply of industrialized nations to lower levels than ever enjoyed previously. At the same time, however, new opportunities for increasing the safety of the blood supply pose new risks and may consume large amounts of healthcare resources. Choosing the course to be followed in these new waters is not simple.

机译：政府官员，管理员和医生被指控提供安全血液供应面临困难的困境。在持续数十年的丙型肝炎（HCV）风险后，无需检测致病症的运输和发现伤害，血腥免疫缺陷病毒，具有长潜伏期，增强的供体筛查和测试工具在工业化国家的同种异体血液供应中减少了传染病风险，以比以往更低的水平降低。然而，同时，新的机会增加血液供应的安全构成新风险，并可能消耗大量的医疗资源。在这些新水域中选择要遵循的课程并不简单。

著录项

来源
《International Symposium on Blood Transfusion》|1999年||共12页
会议地点
作者

展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类输血疗法;
关键词

相似文献

外文文献
中文文献
专利

1. Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies [J] . RileyW., SmalleyB., PulkrabekS., Transfusion: The Journal of the American Association of Blood Banks . 2012,第9期

机译：使用精益技术定义血小板（PLT）输注过程，并采用成本效益评估PLT剂量输注策略
2. Cost-effectiveness analysis: what it really means for transfusion medicine decision making. [J] . Custer B, Hoch JS Transfusion medicine reviews . 2009,第1期

机译：成本效益分析：这对输血医学决策的真正意义。
3. Possible role of artificial oxygen carriers in transfusion medicine: a retrospective analysis on the current transfusion practice. [J] . Yoshiba F, Kawaguchi AT, Hyodo O, Artificial Organs . 2009,第2期

机译：人工氧气载体在输血医学中的可能作用：对当前输血实践的回顾性分析。
4. THE ROLE OF COST-EFFECTIVENESS ANALYSIS IN DEFINING TRANSFUSION MEDICINE POLICY [C] . International Symposium on Blood Transfusion . 1999

机译：成本效益分析在定义输血医学政策中的作用
5. Simulation-based Analysis of Cell-based Regenerative Medicine Production: Focus on Efficiency and Cost-effectiveness [D] . Carr, Sean 2013

机译：基于模拟的细胞再生药物生产分析：关注效率和成本效益
6. The cost of one unit blood transfusion components and cost-effectiveness analysis results of transfusion improvement program [O] . Cenk İndelen, Yeşim Uygun Kızmaz, Ahmet Kar, 2021

机译：一种单位输血组分的成本和输血改善计划的成本效益分析结果
7. MEDICAL TECHNOLOGISTS AT UNIVERSITY HOSPITAL BLOOD TRANSFUSION DEPARTMENTS PLAY AN IMPORTANT ROLE IN EDUCATION IN TRANSFUSION MEDICINE: THE 2009 TRANSFUSION CONFERENCE OF JAPANESE UNIVERSITY HOSPITALS. SURVEILLANCE REPORT ON MEDICAL EDUCATION (1) [O] . Harumi Fujihara, Hiroko Watanabe, Chiaki Yamada, 2011

机译：大学医院的医学技术人员血液输血部门在输血医学教育中发挥着重要作用：2009年日本大学医院输血大会。医学教育监督报告（1）
8. The Implications of Cost-Effectiveness Analysis of Medical Technology. Background Paper Number 2: Case Studies of Medical Technologies. Case Study Number 1: Formal Analysis, Policy Formulation, and End-Stage Renal Disease [R] . 1981

机译：医疗技术成本效益分析的启示。背景文件第2号：医疗技术案例研究。案例研究1：正式分析，政策制定和终末期肾病

THE ROLE OF COST-EFFECTIVENESS ANALYSIS IN DEFINING TRANSFUSION MEDICINE POLICY

摘要

著录项

相似文献

相关主题

期刊订阅